Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:22 pm Purchase |
2024-12-31 | 13G | Structure Therapeutics Inc. GPCR |
JANUS HENDERSON GROUP PLC JHG |
4,159,888 7.300% |
203,010 (+5.13%) |
Filing History |
| 2025-01-13 4:08 pm Purchase |
2025-01-06 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 9,000,000 5.240% |
8,100,000 (+900.00%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
RA Capital Management, L.P. | 5,690,316 3.300% |
-1,534,995 (-21.24%) |
Filing History |
| 2024-11-14 10:26 am Purchase |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
JANUS HENDERSON GROUP PLC JHG |
3,956,878 6.900% |
3,956,878 (New Position) |
Filing History |
| 2024-11-14 09:33 am Sale |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-6,999,999 (Position Closed) |
Filing History |
| 2024-11-12 12:52 pm Purchase |
2024-11-07 | 13G | Structure Therapeutics Inc. GPCR |
Capital Research Global Investors | 10,591,350 6.200% |
10,591,350 (New Position) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Structure Therapeutics Inc. GPCR |
FMR CORP | 23,586,870 14.999% |
23,586,870 (New Position) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
WELLINGTON MANAGEMENT CO LLP | 23,309,313 13.950% |
10,192,335 (+77.70%) |
Filing History |
| 2024-05-30 6:57 pm Purchase |
2024-05-20 | 13G | Structure Therapeutics Inc. GPCR |
RA Capital Management, L.P. | 7,225,311 5.200% |
7,225,311 (New Position) |
Filing History |
| 2024-02-14 09:07 am Purchase |
2023-12-31 | 13G | Structure Therapeutics Inc. GPCR |
AVORO CAPITAL ADVISORS LLC | 6,999,999 5.000% |
6,999,999 (New Position) |
Filing History |
| 2024-02-14 08:45 am Sale |
2023-12-31 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 900,000 0.660% |
-7,040,346 (-88.67%) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Structure Therapeutics Inc. GPCR |
FMR CORP | 17,372,856 12.703% |
3,884,664 (+28.80%) |
Filing |
| 2024-02-09 07:59 am Purchase |
2024-02-08 | 13G | Structure Therapeutics Inc. GPCR |
FIL Limited | 27,912 0.020% |
27,912 (New Position) |
Filing History |
| 2024-02-08 10:03 am Sale |
2023-12-29 | 13G | Structure Therapeutics Inc. GPCR |
WELLINGTON MANAGEMENT CO LLP | 13,116,978 9.430% |
-2,763,258 (-17.40%) |
Filing History |
| 2024-02-06 11:01 am Purchase |
2024-01-31 | 13G | Structure Therapeutics Inc. GPCR |
WELLINGTON MANAGEMENT CO LLP | 15,880,236 11.410% |
15,880,236 (New Position) |
Filing History |
| 2023-12-20 4:36 pm Sale |
2023-12-18 | 13G | Structure Therapeutics Inc. GPCR |
BIOTECHNOLOGY VALUE FUND L P | 2,438,964 1.800% |
-10,221,554 (-80.74%) |
Filing History |
| 2023-10-13 4:00 pm Purchase |
2023-10-04 | 13G | Structure Therapeutics Inc. GPCR |
FMR CORP | 13,488,192 10.756% |
4,073,636 (+43.27%) |
Filing |
| 2023-10-04 12:01 pm Purchase |
2023-10-04 | 13G | Structure Therapeutics Inc. GPCR |
FIL Limited | 13,488,192 10.756% |
7,014,431 (+108.35%) |
Filing |
| 2023-02-13 5:28 pm Purchase |
2023-02-03 | 13G | Structure Therapeutics Inc. GPCR |
BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% |
12,660,518 (New Position) |
Filing History |
| 2023-02-10 09:13 am Purchase |
2023-02-09 | 13G | Structure Therapeutics Inc. GPCR |
FIL Limited | 6,473,761 5.897% |
6,473,761 (New Position) |
Filing |